Aldeyra Therapeutics, Inc. 10-Q filing
Filed 2025-08-07 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-104971
- Form type
- 10-Q
- CIK
- 0001341235
- Primary document
- https://www.sec.gov/Archives/edgar/data/1341235/000095017025104971/aldx-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aldeyra Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-20.6M | - | - |
| Net Income | $-19.7M | - | - |
| Eps Basic | -0.33 | - | - |
| Eps Diluted | -0.33 | - | - |
| Cash And Equivalents | $41.2M | - | - |
| Total Assets | $85.0M | - | - |
| Total Liabilities | $29.7M | - | - |
| Shareholders Equity | $55.3M | - | - |
| Operating Cash Flow | $-21.0M | - | - |